Copyright
©2010 Baishideng Publishing Group Co.
World J Hepatol. Nov 27, 2010; 2(11): 401-405
Published online Nov 27, 2010. doi: 10.4254/wjh.v2.i11.401
Published online Nov 27, 2010. doi: 10.4254/wjh.v2.i11.401
Table 1 The characteristics of patients with chronic hepatitis C treated by pegylated interferon/ribavirin therapy
| Characteristics | ||
| Number of patients | n | 142 |
| Gender | Male; Female | 80; 62 |
| Mean age (range) | Years | 56.0 ± 10.0 (19-71) |
| Body weight | kg | 63.3 ± 10.9 (40-98) |
| Body mass index | kg/m2 | 25.3 ± 3.0 |
| ALT | U/L | 85.3 ± 64.5 |
| HCV RNA titer | KIU/mL | 1927 ± 1415 |
| Previous treatment | Naïve/Retreatment | 97/45 |
| Histology | ||
| Fibrosis | F0/F1/F2/F3/F4 | 4/30/28/21/5 |
| Activity | A0/A1/A2/A3 | 0/32/54/2 |
- Citation: Suzuki H, Kakizaki S, Horiguchi N, Ichikawa T, Sato K, Takagi H, Mori M. Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C. World J Hepatol 2010; 2(11): 401-405
- URL: https://www.wjgnet.com/1948-5182/full/v2/i11/401.htm
- DOI: https://dx.doi.org/10.4254/wjh.v2.i11.401